• Mon, March 19, 2012

by: WOPRAI

AROW SqueezeTrigger Price is $24.73. There is $18,149,710 That Short Sellers Still Need To Cover.

by: WOPRAI

SCBT SqueezeTrigger Price is $31.83. There is $22,916,850 That Short Sellers Still Need To Cover.

by: WOPRAI

Cardiovascular Systems Inc (NASDAQ:CSII), Up By 5.39% ($0.48) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, Ma

by: WOPRAI

ASM International NV (NASDAQ:ASMI), Up By 6.11% ($2.19) From $35.850 After BUYINS.NET Report Predicted Stock Would Go Up Due To

by: WOPRAI

BLUEPHOENIX SOLUTIONS LTD (NASDAQ:BPHX), Down By 40.85% ($0.87) From $2.130 After BUYINS.NET Report Predicted Stock Would Go Do

by: WOPRAI

SEMICONDUCTOR MANUFACT-ADR (NYSE:SMI), Down By 10.62% ($0.29) From $2.730 After BUYINS.NET Report Predicted Stock Would Go Down

by: WOPRAI

UEC SqueezeTrigger Price is $3.94. There is $42,751,200 That Short Sellers Still Need To Cover.

by: WOPRAI

DX SqueezeTrigger Price is $9.40. There is $11,949,696 That Short Sellers Still Need To Cover.

by: WOPRAI

STEL SqueezeTrigger Price is $12.49. There is $6,825,940 That Short Sellers Still Need To Cover.

by: WOPRAI

RSTI SqueezeTrigger Price is $25.77. There is $27,550,707 That Short Sellers Still Need To Cover.

by: WOPRAI

USMO SqueezeTrigger Price is $13.54. There is $11,877,821 That Short Sellers Still Need To Cover.

by: WOPRAI

MMR SqueezeTrigger Price is $13.49. There is $227,786,020 That Short Sellers Still Need To Cover.

by: WOPRAI

CARDIOME PHARMA CORP (NASDAQ:CRME), Down By 53.33% ($1.20) From $2.250 After BUYINS.NET Report Predicted Stock Would Go Down Du

by: WOPRAI

Celldex Therapeutics Inc (NASDAQ:CLDX), Up By 5.22% ($0.23) From $4.410 After BUYINS.NET Report Predicted Stock Would Go Up Due

by: WOPRAI

SAIA INC (NASDAQ:SAIA), Up By 7.38% ($1.20) From $16.250 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Con

by: WOPRAI

STEALTHGAS INC (NASDAQ:GASS), Up By 19.52% ($0.98) From $5.020 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bulli

by: WOPRAI

Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 16.90% ($1.42) From $8.400 After BUYINS.NET Report Predicted Strength After

by: WOPRAI

KERYX BIOPHARMACEUTICALS (NASDAQ:KERX), Up By 14.22% ($0.59) From $4.150 After BUYINS.NET Report Predicted Stock Would Go Up Du

by: WOPRAI

DOLLAR THRIFTY AUTOMOTIVE GP (NYSE:DTG), Up By 5.18% ($3.98) From $76.870 After BUYINS.NET Report Predicted Stock Would Go Up D

by: WOPRAI

QUIDEL CORPORATION (NASDAQ:QDEL), Up By 13.47% ($1.96) From $14.550 After BUYINS.NET Report Predicted Strength After Earnings

by: WOPRAI

HNI CORPORATION (NYSE:HNI), Up By 7.59% ($1.96) After BUYINS.NET SqueezeTrigger Report Released on Monday, February 27th 2012 a

by: WOPRAI

OMNIVISION TECHNOLOGIES INC (NASDAQ:OVTI), Up By 6.17% ($1.14) From $18.490 After BUYINS.NET Report Predicted Stock Would Go Up

by: WOPRAI

Nokia Oyj (NYSE:NOK), Up By 8.12% ($0.41) From $5.050 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Condit

by: WOPRAI

NORDIC AMER TANKER SHIPPING (NYSE:NAT), Up By 20.41% ($2.66) From $13.030 After BUYINS.NET Report Predicted Stock Would Go Up D

by: WOPRAI

CLRO, LIME, TAYCP Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

NYMX, ECTY, FXF, GOODO, IEI, EXAS Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

KOP, KOG, TCL, LEI, RNN, POWL Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SEED, TLK, SIVB, WG, TRAK, EPCT Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

FEIC, MLI, SBS, EVC, IBA, NTRI Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

IHG, CRMT, MRCY, EE, NDSN, TNS Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

EZA, EZU, PVX, GOL, DGX, CRESY Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

DMND, SPRD, IMUC, GTXO, VCSH, VMBS, Removed From Naked Short Lists Today

by: WOPRAI

VCIT, PLPE, Added To Naked Short Lists Today

by: WOPRAI

GTX CORP (OTCBB:GTXO), Down By 9.52% ($0.01) From $0.105 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish C

by: WOPRAI

RADNET INC (NASDAQ:RDNT), Up By 20.24% ($0.68) From $3.360 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish C

by: WOPRAI

HYPERDYNAMICS CORP (NYSE:HDY), Up By 5.26% ($0.07) From $1.330 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bulli

by: WOPRAI

KERYX BIOPHARMACEUTICALS (NASDAQ:KERX), Up By 8.67% ($0.36) From $4.150 After BUYINS.NET Report Predicted Stock Would Go Up Due

by: WOPRAI

CTAS, JBL, ORCL Expected To Be Up After Next Earnings Releases

by: WOPRAI

IGT, NOK, IBCA Expected To Be Up Before Next Earnings Releases

by: WOPRAI

CVX, ZBRA, RGS, MCO, ROK, CNI Expected To Be Up Before Next Earnings Releases

by: WOPRAI

AGP, L, RDEN, CMS, DOW, DHI Expected To Be Up Before Next Earnings Releases

by: WOPRAI

Andreas Bokkenheuser Maintained (X) at Strong Buy with Increased Target to $47 on, Mar 19th, 2012

by: WOPRAI

Matthew Harrison Downgraded (VRTX) to Sell and Held Target at $30 on, Mar 19th, 2012

by: WOPRAI

Michael Rehaut Maintained (SWK) at Hold with Decreased Target to $73 on, Mar 19th, 2012

by: WOPRAI

Brian Bittner Initiated (YUM) at Buy and Held Target at $82 on, Mar 19th, 2012

by: WOPRAI

Brian Ossenbeck Upgraded (UPS) to Buy and Increased Target to $92 on, Mar 19th, 2012

by: WOPRAI

Kevin Fischbeck Maintained (UNH) at Strong Buy with Increased Target to $63 on, Mar 19th, 2012

by: WOPRAI

Brittany Henderson Upgraded (ABT) to Strong Buy and Increased Target to $70 on, Mar 19th, 2012

Matthew Harrison Downgraded (VRTX) to Sell and Held Target at $30 on, Mar 19th, 2012

Matthew Harrison of Morgan Stanley, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Sell and Held Target at $30 on, Mar 19th, 2012.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $49 on, Wednesday, March 14th, 2012

Like: 👍